Thyroid Gland Oncocytic Neoplasm — Trials

Thyroid Gland Oncocytic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04544111	PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer	active not recruiting	Phase 2	19	Memorial Sloan Kettering Cancer CenterOTHER	1	Sep 17, 2026	clinicaltrials
NCT03914300	Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer	active not recruiting	Phase 2	11	National Cancer Institute (NCI)NIH	1	Jul 31, 2026	clinicaltrials
NCT06959641	XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer	recruiting	Phase 2	33	Jochen LorchOTHER	1	Jun 26, 2026	clinicaltrials
NCT02143726	Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer

Data updated 12 days agoSource updated Sep 17, 2026source: clinicaltrials